JPH01309682A - Substrate for animal cell culture - Google Patents
Substrate for animal cell cultureInfo
- Publication number
- JPH01309682A JPH01309682A JP63138178A JP13817888A JPH01309682A JP H01309682 A JPH01309682 A JP H01309682A JP 63138178 A JP63138178 A JP 63138178A JP 13817888 A JP13817888 A JP 13817888A JP H01309682 A JPH01309682 A JP H01309682A
- Authority
- JP
- Japan
- Prior art keywords
- substrate
- animal cell
- cell culture
- cells
- adhesive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000758 substrate Substances 0.000 title claims abstract description 38
- 210000004102 animal cell Anatomy 0.000 title claims abstract description 33
- 238000004113 cell culture Methods 0.000 title claims description 20
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 30
- 229920000307 polymer substrate Polymers 0.000 claims abstract description 15
- 230000001070 adhesive effect Effects 0.000 claims description 25
- 239000000853 adhesive Substances 0.000 claims description 24
- 239000000470 constituent Substances 0.000 claims description 5
- 230000021164 cell adhesion Effects 0.000 claims description 4
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 claims description 2
- 235000001014 amino acid Nutrition 0.000 abstract description 9
- 150000001413 amino acids Chemical class 0.000 abstract description 8
- 239000003431 cross linking reagent Substances 0.000 abstract description 6
- 239000000427 antigen Substances 0.000 abstract description 5
- 102000036639 antigens Human genes 0.000 abstract description 5
- 108091007433 antigens Proteins 0.000 abstract description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 4
- 229920002678 cellulose Polymers 0.000 abstract description 3
- 239000001913 cellulose Substances 0.000 abstract description 3
- 239000004475 Arginine Substances 0.000 abstract description 2
- 239000004471 Glycine Substances 0.000 abstract description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract description 2
- 239000004677 Nylon Substances 0.000 abstract description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract description 2
- 235000003704 aspartic acid Nutrition 0.000 abstract description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 abstract description 2
- 238000011109 contamination Methods 0.000 abstract description 2
- 229920001778 nylon Polymers 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 2
- 230000001464 adherent effect Effects 0.000 abstract 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
- 238000000034 method Methods 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 10
- 239000011324 bead Substances 0.000 description 10
- 102000004196 processed proteins & peptides Human genes 0.000 description 9
- 238000001308 synthesis method Methods 0.000 description 9
- 238000012258 culturing Methods 0.000 description 8
- 229920002307 Dextran Polymers 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000010189 synthetic method Methods 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- -1 polypropylene Polymers 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000012510 hollow fiber Substances 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 125000003172 aldehyde group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000003495 polar organic solvent Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 238000010532 solid phase synthesis reaction Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- VZQHRKZCAZCACO-PYJNHQTQSA-N (2s)-2-[[(2s)-2-[2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]prop-2-enoylamino]-3-methylbutanoyl]amino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VZQHRKZCAZCACO-PYJNHQTQSA-N 0.000 description 1
- CXCHEKCRJQRVNG-UHFFFAOYSA-N 2,2,2-trifluoroethanesulfonyl chloride Chemical compound FC(F)(F)CS(Cl)(=O)=O CXCHEKCRJQRVNG-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- TVZRAEYQIKYCPH-UHFFFAOYSA-N 3-(trimethylsilyl)propane-1-sulfonic acid Chemical compound C[Si](C)(C)CCCS(O)(=O)=O TVZRAEYQIKYCPH-UHFFFAOYSA-N 0.000 description 1
- VCFJLCCBKJNFKQ-UHFFFAOYSA-N 3-[4-(2,5-dioxopyrrol-3-yl)phenyl]pyrrole-2,5-dione Chemical group O=C1NC(=O)C(C=2C=CC(=CC=2)C=2C(NC(=O)C=2)=O)=C1 VCFJLCCBKJNFKQ-UHFFFAOYSA-N 0.000 description 1
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- MBIIDCKRGGUYKK-UHFFFAOYSA-N Cl.COC(=N)C1=CC=C(N=[N+]=[N-])C=C1 Chemical group Cl.COC(=N)C1=CC=C(N=[N+]=[N-])C=C1 MBIIDCKRGGUYKK-UHFFFAOYSA-N 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical group O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 101710176384 Peptide 1 Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 238000006058 Ugi-reaction Methods 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 210000001691 amnion Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 230000004956 cell adhesive effect Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- FRTGEIHSCHXMTI-UHFFFAOYSA-N dimethyl octanediimidate Chemical compound COC(=N)CCCCCCC(=N)OC FRTGEIHSCHXMTI-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N isonitrile group Chemical group N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 238000004810 partition chromatography Methods 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- REQCZEXYDRLIBE-UHFFFAOYSA-N procainamide Chemical compound CCN(CC)CCNC(=O)C1=CC=C(N)C=C1 REQCZEXYDRLIBE-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、動物細胞培養用基体に関する。−船釣に動物
細胞は付着依存性細胞であり大量培養する際、何等かの
基体に付着又は接着させる必要があるが、本発明は基体
への動物細胞接着性を改良した細胞培養用基体に関する
ものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a substrate for culturing animal cells. - Animal cells used in boat fishing are adhesion-dependent cells and need to be attached or adhered to some kind of substrate when being cultured in large quantities, and the present invention relates to a cell culture substrate that has improved animal cell adhesion to the substrate. It is something.
[従来の技術]
従来、動物の生産する生理活性物質など有用成分を得る
ために、動物細胞の大量培養によって生産する方法が検
討されてきた。しかしながら動物細胞の培養には特殊な
細胞を除いて基体に接着していないと増殖できない接着
依存性細胞が一般的である。これらあ細胞は、多糖類や
合性高分子をポリマー基体とする場合、通常基体に対す
る接着性が充分でなく細胞の進展・増殖が順調に行われ
ないのが実状である。このため動物細胞の接着性改良の
ため基体の表面に正の荷電を持たせる方法(Cytod
ex 1 、ファルマシア製マイクロキャリアー)やコ
ラーゲンをコーティング処理する方法(Cyt。[Prior Art] Conventionally, in order to obtain useful components such as physiologically active substances produced by animals, methods of producing them by mass culturing animal cells have been studied. However, in animal cell culture, except for special cells, adhesion-dependent cells that cannot proliferate unless they are attached to a substrate are commonly used. When these cells are made of polysaccharides or synthetic polymers as a polymer substrate, the actual situation is that the adhesion to the substrate is usually insufficient and the cells do not progress or proliferate smoothly. Therefore, in order to improve the adhesion of animal cells, a method of positively charging the surface of the substrate (Cytod
ex 1, Pharmacia microcarrier) and collagen coating method (Cyt.
dex3.ファルマシア製マイクロキャリアー)が用い
られてぎた。dex3. Microcarriers manufactured by Pharmacia) have been used.
[発明が解決しようとする問題点]
しかしながら、従来用いられてきたこれらの動物細胞培
養用基体のうち表面に正の荷電を持たせた基体は、接着
性が充分でないのが実状であり、またコラーゲンをコー
ティング処理した基体は滅菌操作や大量培養操作におい
て、剥離や変性を受けることがしばしば見られる等の問
題があった。[Problems to be solved by the invention] However, among these conventionally used animal cell culture substrates, the substrates whose surfaces are positively charged do not have sufficient adhesive properties, and Substrates coated with collagen often suffer from peeling or denaturation during sterilization operations or mass culture operations.
また基体の表面処理材料が生体内から得られた成分やそ
の誘導体を用いていることや、上記の動物細胞培養基体
を使用する条件として培地中に牛胎児血清(以下FC5
と記載)を必要とすることから・大量培養を行った後、
培養液から有用成分だけを精製するのは非常に困難であ
フた。In addition, the surface treatment material of the substrate uses components obtained from in vivo or their derivatives, and the condition for using the above animal cell culture substrate is that the medium contains fetal bovine serum (hereinafter referred to as FC5).
・After mass culture,
It was extremely difficult to purify only useful components from the culture solution.
[問題点を解決するための手段]
本発明者らは、上記問題点に鑑みて動物細胞培養を行う
際、接着性付与良好で有用成分の精製が容易な動物細胞
培養用基体を見いだすべく鋭意検討した結果、本発明に
到達した。すなわち、本発明は動物細胞培養用のポリマ
ー基体に対してアルギニン−グリシン−アスパラギン酸
を必須構成単位として有する接着性ペプチドを共有結合
させてなる動物細胞の接着性を改良した動物細胞培養用
基体である。[Means for Solving the Problems] In view of the above-mentioned problems, the present inventors have worked diligently to find a substrate for animal cell culture that provides good adhesion and allows easy purification of useful components when culturing animal cells. As a result of study, we have arrived at the present invention. That is, the present invention provides a substrate for animal cell culture that has improved adhesion of animal cells by covalently bonding an adhesive peptide having arginine-glycine-aspartic acid as an essential constituent unit to a polymer substrate for animal cell culture. be.
本発明に用いられる接着性ペプチドとしては、以下の3
つのアミノ酸すなわちアルギニン(以下Argと記載)
、グリシン(以下G1yと記載)、アスパラギン酸(以
下Aspと記載)を必須成分として結合した一般式
%式%(
X、 、X2:Oまたは1〜30個のアミノ酸残基のペ
プチド鎖。アミノ酸の種類及び結合
の順序は特に限定しない。The following three adhesive peptides are used in the present invention.
one amino acid, namely arginine (hereinafter referred to as Arg)
, glycine (hereinafter referred to as G1y), and aspartic acid (hereinafter referred to as Asp) bonded as essential components. The type and the order of bonding are not particularly limited.
を構成成分とする分子量3 、000以下のペプチドが
あげられる。好ましくは上記Ar5−Gly−Aspに
セリン(以下Serと記載)の結合した一般式
%式%(2)
Y、、’/2:Oまたは1〜30個のアミノ酸残基のペ
プチド鎖。アミノ酸の種類及び結合
の順序は特に限定しない。Examples include peptides having a molecular weight of 3,000 or less and having as a constituent component. Preferably, a peptide chain of the general formula % formula % (2) Y,,'/2:O or 1 to 30 amino acid residues in which serine (hereinafter referred to as Ser) is bonded to Ar5-Gly-Asp. The types of amino acids and the order of bonding are not particularly limited.
を構成成分とする分子量3 、000以下のペプチドで
あり、特に好ましくは疎水性のアミノ酸であるプロリン
(以下Proと記載)を含む一般式%式%(3)
Z1$Z2:Proを1個以上含む1〜30個のアミノ
酸残基のペプチド鎖。アミノ酸の種類及び
結合の順序は特に限定しない。A peptide having a molecular weight of 3,000 or less and particularly preferably containing the hydrophobic amino acid proline (hereinafter referred to as Pro). (3) Z1$Z2: One or more Pro A peptide chain of 1 to 30 amino acid residues containing. The types of amino acids and the order of bonding are not particularly limited.
を構成成分とする分子−m3,000以下のペプチドで
ある。一般式(1)、(2)、(3)におけるX4、×
2、Y4、Y2.2、.22のアミノ酸残基な構成する
アミノ酸としては特に限定されず、生化学データブック
I P29〜P59(日本生化学金線・東京化学同
人発行)に記載されているアミノ酸が挙げられる。It is a peptide with a molecular size of less than 3,000 m. X4 in general formulas (1), (2), and (3), x
2, Y4, Y2.2, . The amino acids constituting the 22 amino acid residues are not particularly limited, and include the amino acids listed in Biochemical Data Book I P29 to P59 (Nippon Biochemical Kinsen, published by Tokyo Kagaku Dojin).
本発明に係わる接着性ペプチドに用いられるアミノ酸は
、L体、0体どちらでもよいが、好ましくはL体である
。また構成アミノ酸であるProは、接着性ペプチドに
疎水性の性質を与えることから、ポリマー基体に結合反
応させる際DMF (ジメチルホルムアミド)等の有機
溶媒を反応溶媒として用いることが出来ることから、従
来の水溶液中の反応と比較して反応効率の向上が図れる
。The amino acid used in the adhesive peptide according to the present invention may be either L-form or 0-form, but preferably L-form. In addition, since the constituent amino acid Pro imparts hydrophobic properties to the adhesive peptide, organic solvents such as DMF (dimethylformamide) can be used as a reaction solvent when bonding to a polymer substrate. The reaction efficiency can be improved compared to the reaction in an aqueous solution.
本発明に係わる接着性ペプチドの分子量は、通。The molecular weight of the adhesive peptide according to the present invention is approximately 100%.
常3,000以下である。3 、000を越える場合、
抗原になる可能性があり、10,000以上では完全抗
原として作用することから本発明に使用するペプチドの
分子量を3,000以下とした。Usually less than 3,000. If it exceeds 3,000,
The molecular weight of the peptide used in the present invention was set to 3,000 or less since it has the potential to become an antigen and a molecular weight of 10,000 or more acts as a complete antigen.
ペプチドの合成方法としては特に限定しないが、液相法
、固相法および固相法を応用した自動合成装置による合
成方法などが挙げられる。これらの合成方法の詳細につ
いては、゛生化学実験講座・タンパク質の化学IV P
2O7〜P495 (日本生化学金線・東京化学同人発
行)、続生化学実験講座・タンパク質の化学(下) P
641−P694 (日本生化学金線・東京化学同人発
行)等に記載されている。Methods for synthesizing peptides include, but are not particularly limited to, liquid phase methods, solid phase methods, and synthesis methods using automatic synthesizers applying solid phase methods. For details on these synthesis methods, please refer to "Biochemistry Experiment Course/Protein Chemistry IV P.
2O7~P495 (Published by Nippon Biochemical Gold Line/Tokyo Kagaku Dojin), Continued Biochemistry Experiment Course/Chemistry of Proteins (Part 2) P
641-P694 (Nippon Seikagaku Kinsen, published by Tokyo Kagaku Dojin), etc.
動物培養用基体を作成するためのポリマー基体としては
、従来用いられているセルロース、デキストラン、キチ
ン等の多糖類:ナイロン、ガラス繊維、ポリビニルアル
コール、ポリエステル、ポリプロピレン、ポリカーボネ
ート、ウレタン樹脂、フッ素樹脂、シリコーン樹脂等の
合成高分子が挙げられる。これらポリマー基体は、ビー
ズ状、フオーム状、エラストマー状、フィルム状、多孔
膜、中空管、中空糸、繊維等成形品に加工された物が用
いられる。これらの中で好ましいものは、大量培養の効
率の面からビーズ状のポリマー基体である。Polymer substrates for creating animal culture substrates include conventionally used polysaccharides such as cellulose, dextran, and chitin: nylon, glass fiber, polyvinyl alcohol, polyester, polypropylene, polycarbonate, urethane resin, fluororesin, and silicone. Examples include synthetic polymers such as resins. These polymer substrates may be processed into molded products such as beads, foams, elastomers, films, porous membranes, hollow tubes, hollow fibers, and fibers. Among these, bead-shaped polymer substrates are preferred from the standpoint of efficiency in mass culture.
本発明に用いる接着性ペプチドを動物培養用基体に用い
るには、本ペプチドを基体に共有結合させる必要がある
。結合させる方法としては特に限定しないが、基体表面
の水酸基、アミノ基、カルボン酸基等と接着性ペプチド
とを架橋剤を利用して結合させる合成法、基体表面に反
応性官能基がない場合反応性官能基を導入Lノで結合さ
せる合成法等が挙げられる。例えば、臭化シアン、酸ア
ジド、水溶性カルボジイミド等を利用したペプチド結合
合成法;基体に導入した芳香族アミノ基と亜硝酸ナトリ
ウムとを反応させて得たジアゾニウム化合物を利用する
ジアゾ合成法;ハロゲン化アセチル誘導体、トリアジニ
ル誘導体を利用するアルギル化法;グルタルアルデヒド
等のアルデヒド基と基体のアミノ基との反応を利用する
シップ塩基□形成合成法;カルボシル基、アミ7ノ基、
アルデヒド基及びイソニトリル基を共存させて縮合を行
うUgi反応合成法;トレシルエステルを利用するトレ
シルクロリド合成法;スペリン酸ジ−N−ヒドロキシス
クシンイミドエステル、酒石酸シート1−・ヒドロキシ
スクシンイミドエステ等ルの活性エステル基を用いる合
成法;ジメチルスベロイミデートニ塩基酸、メチル−4
−メルカプトブチルイミデート塩酸塩、メチル−4−ア
ジドベンゾイミデート塩酸塩等のイミドエステル基を用
いる合成法;p−フェニレンビスマレイミド等のマレイ
ミド基を用いる合成法;基体の水酸基をN、N’−カル
ボニルジイミダゾールで活性化する合成法が挙げられる
。上記合成法は、水溶液中やDMFやピリジンのような
極性有機溶媒中で行うことができる。好ましい溶媒は極
性有機溶媒である。In order to use the adhesive peptide used in the present invention on a substrate for animal culture, it is necessary to covalently bond the peptide to the substrate. The bonding method is not particularly limited, but includes a synthetic method in which a hydroxyl group, an amino group, a carboxylic acid group, etc. on the surface of the substrate is bonded to an adhesive peptide using a crosslinking agent, and a reaction when there is no reactive functional group on the surface of the substrate. Examples include a synthetic method in which a sexual functional group is bonded to an introduced L-. For example, peptide bond synthesis method using cyanogen bromide, acid azide, water-soluble carbodiimide, etc.; diazo synthesis method using diazonium compound obtained by reacting an aromatic amino group introduced into a substrate with sodium nitrite; halogen Algylation method that utilizes acetyl derivatives and triazinyl derivatives; Ship base formation synthesis method that utilizes the reaction between aldehyde groups such as glutaraldehyde and amino groups of the substrate; carbosyl group, amine 7 group,
Ugi reaction synthesis method in which condensation is carried out in the coexistence of aldehyde groups and isonitrile groups; tresyl chloride synthesis method using tresyl ester; Synthetic method using active ester group; dimethylsuberoimidate dibasic acid, methyl-4
- Synthesis method using imide ester groups such as mercaptobutyrimidate hydrochloride and methyl-4-azidobenzimidate hydrochloride; Synthesis method using maleimide groups such as p-phenylene bismaleimide; -Synthetic method activated with carbonyldiimidazole. The above synthetic method can be carried out in an aqueous solution or in a polar organic solvent such as DMF or pyridine. Preferred solvents are polar organic solvents.
架橋剤をポリマー基体に架橋剤を利用して結合させる方
法としては、架橋剤をポリマー基体に直接結合させる方
法、ポリマー基体にポリエチレングリコールやポリプロ
ピレングリコール等をグラフトさせその末端に上記架橋
剤を結合させる方法が挙げられる。Methods of bonding a crosslinking agent to a polymer substrate using a crosslinking agent include a method of directly bonding a crosslinking agent to a polymer substrate, and a method of grafting polyethylene glycol, polypropylene glycol, etc. to a polymer substrate and bonding the above crosslinking agent to the terminal thereof. There are several methods.
動物細胞の培養における細胞培養基体の使用方法につい
ては、通常の方法で行われ特に限定されない。例えば、
接着性ペプチドを共有結合処理1ノたビーズを培養液中
に浮遊させて低速度で撹拌を行うことで動物細胞をビー
ズ表面に接着させ培養する方法;接着性ペプチドを共有
結合処理したシャーレ、ルーびん、ローラーびん等の上
で動物細胞を培養する方法;接着性ペプチドを共有結合
処理した中空糸に培養液を還流させ動物細胞を中空糸内
面に接着させ培養する方法;接着性ペプチドを共有結合
処理したビーズを充填したカラムを用いる方法;接着性
ペプチドを共有結合処理したマルチディスク、マルチト
レーを用いる方法等が挙げられる。The method for using the cell culture substrate in culturing animal cells is not particularly limited and may be carried out in a conventional manner. for example,
A method in which animal cells are cultured by adhering to the bead surface by suspending beads treated with covalently bonded adhesive peptides in a culture medium and stirring at low speed; A method of culturing animal cells on a bottle, roller bottle, etc.; A method of culturing animal cells by circulating the culture solution through a hollow fiber that has been treated with an adhesive peptide to covalently bond it to the inner surface of the hollow fiber; Examples include a method using a column filled with treated beads; a method using a multi-disc or multi-tray treated with covalently bonded adhesive peptides, and the like.
本発明に係わる動物細胞としては特に限定されないが、
生理活性物質など有用成分を産出する細胞が挙げられる
。例えば、インターフェロンを生産する羊膜または腎臓
に由来する上皮細胞など;ウロキナーゼを生産する腎細
胞;インシュリンを生産する膵臓起源の細胞等、動物の
各組織の細胞が挙げられる。また、ワクチン等の製造の
ため上記培養細胞を宿主として水痘ウィルスや肝炎ウィ
ルスを接種し培養することも可能である。Animal cells related to the present invention are not particularly limited, but include:
Examples include cells that produce useful components such as physiologically active substances. Examples include cells from various animal tissues, such as epithelial cells derived from amnion or kidney that produce interferon; renal cells that produce urokinase; and cells of pancreatic origin that produce insulin. It is also possible to inoculate and culture the varicella virus or hepatitis virus using the cultured cells as hosts for the production of vaccines and the like.
[実施例]
以下、実施例により本発明を更に説明するが、本発明は
これに限定されるものではない。[Examples] Hereinafter, the present invention will be further explained with reference to Examples, but the present invention is not limited thereto.
製造例1
接着性ポリペプチドの合成
Merrifield方式によるペプチド自動合成14
iを用いて合成を行った。αアミノ基の保護にはBoa
基を用い、セファデックスゲル、側−セルロースイオン
交換クロマトグラフィーおよび分配クロマトグラフィー
によって精製を行い、HPLC(高速液体クロマトグラ
フィー)上単一ピークを示す接着性合成ペプチド表−1
を得た。Production Example 1 Synthesis of adhesive polypeptide Automated peptide synthesis by Merrifield method 14
Synthesis was performed using i. Boa for protection of α-amino group
Adhesive synthetic peptides showing a single peak on HPLC (high performance liquid chromatography) after purification by Sephadex gel, side-cellulose ion exchange chromatography, and partition chromatography.
I got it.
表−1接着性合成ペプチド
実施例1
架橋デキストランビーズにDMF溶媒中ジイソシアン酸
へキサメチレンを反応させた後、側鎖のイソシアネート
基を加水分解してアミノ化を行った。Table 1 Adhesive Synthetic Peptide Example 1 After reacting crosslinked dextran beads with hexamethylene diisocyanate in a DMF solvent, the isocyanate groups in the side chains were hydrolyzed and aminated.
次いでスペリン酸ジ−N−ヒドロキシスクシンイミジル
(DSS)でアミノ基を活性化し緩衝溶液中にて上記の
接着性合成ペプチド−1と反応させて動物細胞培養用基
体を得た。Next, the amino groups were activated with di-N-hydroxysuccinimidyl perate (DSS) and reacted with the above adhesive synthetic peptide-1 in a buffer solution to obtain a substrate for animal cell culture.
実施例2.3
架橋デキストランビーズに接着性合成ペプチド−2,3
を実施例1に従って反応させ動物細胞培養用基体を得た
。Example 2.3 Adhesive synthetic peptide-2,3 to cross-linked dextran beads
were reacted according to Example 1 to obtain a substrate for animal cell culture.
実施例4
架橋デキストランビーズの表面水酸基をN、N’−力ル
ボニルジイミダゾールで活性化しDMF溶媒中にて上記
の接着性合成ペプチド−3と反応させて動物細胞培養用
基体を得た。Example 4 The surface hydroxyl groups of cross-linked dextran beads were activated with N,N'-carbonyldiimidazole and reacted with the above adhesive synthetic peptide-3 in a DMF solvent to obtain a substrate for animal cell culture.
実施例5
架橋デキストランビーズに接着性合成ペプチド−4を実
施例4に従って反応させ動物細胞培養用基体を得た。Example 5 Cross-linked dextran beads were reacted with adhesive synthetic peptide-4 according to Example 4 to obtain a substrate for animal cell culture.
比較例1
架橋デキストランビーズの表面をN、N−)+7メーf
)L−2−ヒト”ロ1シー1ミノフ0ロヒ0ル荷電基で
置換したCytodex 2 (7アルマシア製)
を動物細胞培養用基体とした。Comparative Example 1 The surface of cross-linked dextran beads was
) Cytodex 2 (manufactured by 7 Almasia) substituted with a charged group
was used as a substrate for animal cell culture.
比較例2
架橋デキストランビーズの表面をブタ表皮より得た変性
コラーゲン(MW 60,000〜200,000)で
処理したCytodex 3 (ファルマシア製)を動
物細胞培養用基体とした。Comparative Example 2 Cytodex 3 (manufactured by Pharmacia), in which the surface of cross-linked dextran beads was treated with denatured collagen (MW 60,000 to 200,000) obtained from pig epidermis, was used as a substrate for animal cell culture.
試験例1
(1)接着性合成ペプチドの固定化密度接着性合成ペプ
チド−3を固定化した実施例3.4の固定化密度を測定
し、反応条件による差を調べた。ポリマー基体表面にお
ける炭素原子、窒素原子の割合を測定したところ、DM
Fの溶媒で反応させた実施例4の方が固定化密度で70
%増加していた。Test Example 1 (1) Immobilization Density of Adhesive Synthetic Peptide The immobilization density of Example 3.4 in which adhesive synthetic peptide-3 was immobilized was measured, and differences due to reaction conditions were investigated. When the ratio of carbon atoms and nitrogen atoms on the surface of the polymer substrate was measured, it was found that DM
Example 4, in which the reaction was carried out in the solvent F, had a higher immobilization density of 70
% increase.
(2)動物細胞の接着性、増殖性の評価実施例1〜5及
び比較例1.2にて作成した動物細胞培養用基体を用い
細胞培養を行った。細胞は血管内皮細胞を用い、培養液
はDulbecco’s Modified Eagl
e’s Medium (以下DMEMと記載する)、
及びDMEMにFe2をlOχ加えた培養液を用いた。(2) Evaluation of adhesion and proliferation of animal cells Cell culture was performed using the animal cell culture substrates prepared in Examples 1 to 5 and Comparative Example 1.2. The cells used were vascular endothelial cells, and the culture medium was Dulbecco's Modified Eagle.
e's Medium (hereinafter referred to as DMEM),
A culture solution prepared by adding 1Ox of Fe2 to DMEM was used.
培養後、位相差顕微鏡及び走査型電子顕微鏡にて接着性
及び増殖性の観察を行い、結果を表−2に示した。After culturing, adhesion and proliferation were observed using a phase contrast microscope and a scanning electron microscope, and the results are shown in Table 2.
表−2動物細胞の接着性、増殖性
○:良好、 △:やや不良、 ×:不良比較に用いたC
ytodex−2,3は、Fe2を含まぬDMEM培地
に於て細胞接着性及び増殖性は、実施例の基体に比べて
劣っていた。Fe2の添加によって改善されるものの、
培地中よりFC5成分を除くのはゲルろ過繰り返す必要
があり完全に除くのは困難であった。Table 2 Adhesion and proliferation of animal cells ○: Good, △: Slightly poor, ×: Poor C used for comparison
The cell adhesion and proliferation of ytodex-2 and 3 in Fe2-free DMEM medium were inferior to those of the substrates of Examples. Although it is improved by adding Fe2,
Removing the FC5 component from the medium required repeated gel filtration, and it was difficult to remove it completely.
[発明の効果コ
本発明の動物細胞培養用基体は、ポリマー基体に対して
Arg−Gly−Aspe必須構成単位として有する接
着性ペプチドを共有結合させていることから、次のよう
な効果を奏する。■フィブロネクチン等細胞接着性ペプ
チドを含む牛胎児血清(以下FC5と記載)を加えなく
ても、ポリマー基体に対する生細胞の接着性は良好とな
る。■上記FCSを加えなくても細胞接着に伴う培養が
良好に行われることから、本発明の動物細胞培養用基体
による細胞大量培養によって生理活性を有する薬理成分
を得る場合、FC5中に含まれる抗原となりうる成分の
混入がなくなり患者にとって安全性が高まる。また本発
明で用いられる接着性ペプチドは低分子量であることか
ら、これ自体が抗原となる可能性が低減され、安全性は
さらに高まる。■本発明の接着性ペプチドは、共有結合
で基体に結合されていることから基体からの脱落もなく
、滅菌操作も安全に行うことが可能となる。■接着性ペ
プチド中にProを含有した物は、有機溶媒中にて反応
することが可能となり反応効率は格段に向上する。[Effects of the Invention] The animal cell culture substrate of the present invention has the following effects because the adhesive peptide having Arg-Gly-Aspe as an essential constituent unit is covalently bonded to the polymer substrate. (2) Good adhesion of living cells to the polymer substrate is achieved even without the addition of fetal calf serum (hereinafter referred to as FC5) containing cell adhesive peptides such as fibronectin. ■Culture with cell adhesion can be performed well even without the addition of FCS, so when obtaining physiologically active pharmacological components by mass culturing cells using the animal cell culture substrate of the present invention, antigens contained in FC5 can be used. This eliminates the possibility of contamination with potentially dangerous ingredients, increasing safety for patients. Furthermore, since the adhesive peptide used in the present invention has a low molecular weight, the possibility that it itself becomes an antigen is reduced, further increasing safety. (2) Since the adhesive peptide of the present invention is covalently bonded to the substrate, it does not fall off from the substrate and can be safely sterilized. (2) Adhesive peptides containing Pro can react in organic solvents, and the reaction efficiency is significantly improved.
Claims (1)
パラギン酸を必須構成単位として有する接着性ペプチド
を共有結合させてなる動物細胞の接着性を改良した動物
細胞培養用基体。1. An animal cell culture substrate with improved animal cell adhesion, which is obtained by covalently bonding an adhesive peptide having arginine-glycine-aspartic acid as an essential constituent unit to a polymer substrate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63138178A JPH01309682A (en) | 1988-06-03 | 1988-06-03 | Substrate for animal cell culture |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63138178A JPH01309682A (en) | 1988-06-03 | 1988-06-03 | Substrate for animal cell culture |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH01309682A true JPH01309682A (en) | 1989-12-14 |
Family
ID=15215874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63138178A Pending JPH01309682A (en) | 1988-06-03 | 1988-06-03 | Substrate for animal cell culture |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH01309682A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04173086A (en) * | 1990-11-07 | 1992-06-19 | Sakai Eng Kk | Carrier for culturing animal cell |
| JPH04217700A (en) * | 1990-10-26 | 1992-08-07 | Fuji Photo Film Co Ltd | Cm-chitin derivative and its use |
| WO2000049135A3 (en) * | 1999-01-21 | 2000-12-14 | Adv Med Solutions Ltd | Substrate for cell growth |
| US8168433B2 (en) | 2008-01-30 | 2012-05-01 | Corning Incorporated | Cell culture article and screening |
| US8329469B2 (en) | 2008-01-30 | 2012-12-11 | Geron Corporation | Swellable (meth)acrylate surfaces for culturing cells in chemically defined media |
-
1988
- 1988-06-03 JP JP63138178A patent/JPH01309682A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04217700A (en) * | 1990-10-26 | 1992-08-07 | Fuji Photo Film Co Ltd | Cm-chitin derivative and its use |
| JPH04173086A (en) * | 1990-11-07 | 1992-06-19 | Sakai Eng Kk | Carrier for culturing animal cell |
| WO2000049135A3 (en) * | 1999-01-21 | 2000-12-14 | Adv Med Solutions Ltd | Substrate for cell growth |
| US8168433B2 (en) | 2008-01-30 | 2012-05-01 | Corning Incorporated | Cell culture article and screening |
| US8329469B2 (en) | 2008-01-30 | 2012-12-11 | Geron Corporation | Swellable (meth)acrylate surfaces for culturing cells in chemically defined media |
| US8354274B2 (en) | 2008-01-30 | 2013-01-15 | Geron Corporation | Synthetic surfaces for culturing cells in chemically defined media |
| US8530236B2 (en) | 2008-01-30 | 2013-09-10 | Corning Incorporated | Swellable (meth)acrylate surfaces for culturing cells in chemically defined media |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0494216B1 (en) | Surfaces having desirable cell adhesive effects | |
| CN101405384B (en) | Cell culture substrate, preparation method and uses | |
| Tamada et al. | Fibroblast growth on polymer surfaces and biosynthesis of collagen | |
| Drumheller et al. | Multifunctional poly (ethylene glycol) semi‐interpenetrating polymer networks as highly selective adhesive substrates for bioadhesive peptide grafting | |
| US6759388B1 (en) | Surfactants that mimic the glycocalyx | |
| US9987393B2 (en) | Covalently cross linked hydrogels and methods of making and using same | |
| EP0359996A2 (en) | Synthetic amino acid-and/or peptide-containing graft copolymers | |
| JP2565363B2 (en) | Method for producing a substrate that does not form thrombogen | |
| WO1987006007A1 (en) | Immobilized physiologically active material | |
| JP2014509590A (en) | Synthetic coating for cell culture | |
| JP5000439B2 (en) | Cell culture carrier | |
| JPH01309682A (en) | Substrate for animal cell culture | |
| CN101810888B (en) | Preparation method for material with high density fixed biologically functional molecule | |
| JP4593581B2 (en) | Cell culture carrier | |
| JPH04213311A (en) | Copolymer of propenamide derivative with nonionic monomer and its use | |
| EP0596315B1 (en) | A method of attaching dialdehyde starch to a surface and products produced by that method | |
| Anderson et al. | Extracellular Matrix‐Like Surfactant Polymers Containing Arginine‐Glycine‐Aspartic Acid (RGD) Peptides | |
| CN102206409B (en) | Hydrogel forming covalent cross-linking rapidly under mild conditions and preparation method thereof | |
| CN118119657A (en) | Hydrogels and sterilized dried hydrogel-forming articles | |
| JPS63304000A (en) | Immobilization method for biological substances | |
| WO2022168870A1 (en) | Microcarrier for cell culture and cell culture method | |
| JPH05276945A (en) | Production of formed silicone material holding immobilized physiologically active substance | |
| CN108659168B (en) | A kind of double biomimetic polymer and its preparation method and application | |
| JP2010148486A (en) | Carrier for cell culture | |
| JPH01305960A (en) | Substrate and vivo composite artificial organ |